GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Go back to GSK and CureVac to Restructure Collaboration into New Licensing Agreement| Clearview Acquisitions, Inc. (NASDAQ: CVAC) | Delayed: 4.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.66 | 52 Week High | $2.10 | |||
| Open | $4.66 | 52 Week Low | $1.50 | |||
| Day High | $4.66 | P/E | N/A | |||
| Day Low | $4.66 | EPS | $-0.04 | |||
| Volume | 228,252 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.37 -0.35 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.72 | 52 Week High | $45.58 | |||
| Open | $50.18 | 52 Week Low | $37.82 | |||
| Day High | $50.72 | P/E | N/A | |||
| Day Low | $50.18 | EPS | $0.00 | |||
| Volume | 518,605 | |||||
